Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver

被引:18
作者
Herrmann, J [1 ]
Abriss, B [1 ]
van de Leur, E [1 ]
Weiskirchen, S [1 ]
Gressner, AM [1 ]
Weiskirchen, R [1 ]
机构
[1] Rhein Westfal TH Aachen, Univ Hosp, Inst Clin Chem & Pathobiochem, D-52074 Aachen, Germany
关键词
D O I
10.1007/s00705-004-0300-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The potential indications for gene therapy are expanding continuously. Currently, hepatotropic adenoviruses are useful vector systems for targeting liver in experimental animal models. Although this gene delivery technique is widely distributed, there is no common sense about how these viruses should be applied. In general, the local delivery into portal vein and the systemic application via tail vein induces above all substantial transgene expression. We here comparatively analysed both methods and found that the systemic administration of an adeno-virus expressing the green fluorescent protein resulted in a stronger infiltration, a more homogenous distribution, and a higher inter-individual reproducibility of reporter gene expression in rat liver than organ-specific administration via the portal vein.
引用
收藏
页码:1611 / 1617
页数:7
相关论文
共 8 条
[1]   Adenoviral expression of a transforming growth factor-β1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats -: art. no. 29 [J].
Arias, M ;
Sauer-Lehnen, S ;
Treptau, J ;
Janoschek, N ;
Theuerkauf, I ;
Buettner, R ;
Gressner, AM ;
Weiskirchen, R .
BMC GASTROENTEROLOGY, 2003, 3 (1)
[2]   Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats [J].
Chen, LM ;
Chao, L ;
Chao, J .
HUMAN GENE THERAPY, 1997, 8 (03) :341-347
[3]   Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats [J].
Dooley, S ;
Hamzavi, J ;
Breitkopf, K ;
Wiercinska, E ;
Said, HM ;
Lorenzen, J ;
Ten Dijke, P ;
Gressner, AM .
GASTROENTEROLOGY, 2003, 125 (01) :178-191
[4]   Liver-directed gene therapy: promises, problems and prospects at the turn of the century [J].
Ghosh, SS ;
Takahashi, M ;
Thummala, NR ;
Parashar, B ;
Chowdhury, NR ;
Chowdhury, JR .
JOURNAL OF HEPATOLOGY, 2000, 32 :238-252
[5]   Genetic heterogeneity in response to adenovirus gene therapy [J].
Lefesvre, P ;
Attema, J ;
Lemckert, A ;
Havenga, M ;
van Bekkum, D .
BMC MOLECULAR BIOLOGY, 2003, 4
[6]   Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats [J].
Nakamura, T ;
Sakata, R ;
Ueno, T ;
Sata, M ;
Ueno, H .
HEPATOLOGY, 2000, 32 (02) :247-255
[7]   Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat [J].
Qi, Z ;
Atsuchi, N ;
Ooshima, A ;
Takeshita, A ;
Ueno, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2345-2349
[8]   Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts [J].
Weiskirchen R. ;
Kneifel J. ;
Weiskirchen S. ;
van de Leur E. ;
Kunz D. ;
Gressner A.M. .
BMC Cell Biology, 1 (1)